Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Orellana, Cristhian
32  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Real clinical experience after one year of treatment with t..:

Naranjo Muñoz, Javier ; Borrego, Francisco ; Rocha, José Luis...
2296-858X.  , 2023
Link: http://hdl.handle.net/10..
 
?
2

Perfil clínico de los pacientes tratados con evolocumab en ..:

Goicoechea, M ; Alvarez, Vicente ; Segarra, Alfonso...
Nefrologia, 2021, vol. 42, num. 3, p. 301-310.  , 2022
Link: https://hdl.handle.net/1..
 
?
3

Trends in COVID-19 Outcomes in Kidney Transplant Recipients..:

Villanego, Florentino ; Vigara, Luis Alberto ; Alonso, Marta...
http://hdl.handle.net/10668/19873.  , 2022
Link: http://hdl.handle.net/10..
 
?
4

Real clinical experience after one year of treatment with t..:

Naranjo, Javier ; Borrego, Francisco ; Rocha, José Luis...
2296-858X.  , 2022
Link: http://hdl.handle.net/10..
 
?
5

Real clinical experience after one year of treatment with t..:

Naranjo, Javier ; Borrego, Francisco ; Rocha, José Luis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557750/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Lipid profile of patients treated with evolocumab in Spanis..:

Goicoechea, Marian ; Álvarez, Vicente ; Segarra, Alfonso...
http://hdl.handle.net/10668/22413.  , 2021
Link: http://hdl.handle.net/10..
 
?
7

Tratamiento con inhibidores de PCSK9 en pacientes con enfer..:

José Manuel Amaro ; Florentino Villanego ; Javier Naranjo...
http://www.sciencedirect.com/science/article/pii/S0211699522001795.  , 2023
Link: https://doi.org/10.1016/..
 
?
8

Image_5_Real clinical experience after one year of treatmen..:

Javier Naranjo ; Francisco Borrego ; José Luis Rocha...
doi:10.3389/fmed.2022.987092.s005.  , 2022
Link: https://doi.org/10.3389/..
 
?
9

Real clinical experience after one year of treatment with t..:

Javier Naranjo ; Francisco Borrego ; José Luis Rocha...
https://www.frontiersin.org/articles/10.3389/fmed.2022.987092/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
10

Image_2_Real clinical experience after one year of treatmen..:

Javier Naranjo ; Francisco Borrego ; José Luis Rocha...
doi:10.3389/fmed.2022.987092.s002.  , 2022
Link: https://doi.org/10.3389/..
 
?
11

Image_1_Real clinical experience after one year of treatmen..:

Javier Naranjo ; Francisco Borrego ; José Luis Rocha...
doi:10.3389/fmed.2022.987092.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
12

Table_1_Real clinical experience after one year of treatmen..:

Javier Naranjo ; Francisco Borrego ; José Luis Rocha...
doi:10.3389/fmed.2022.987092.s007.  , 2022
Link: https://doi.org/10.3389/..
 
?
13

Lipid profile of patients treated with evolocumab in Spanis..:

Marian Goicoechea ; Vicente Álvarez ; Alfonso Segarra...
http://www.sciencedirect.com/science/article/pii/S2013251422000682.  , 2022
Link: https://doi.org/10.1016/..
 
?
14

Perfil clínico de los pacientes tratados con evolocumab en ..:

Marian Goicoechea ; Vicente Álvarez ; Alfonso Segarra...
http://www.sciencedirect.com/science/article/pii/S0211699521001338.  , 2022
Link: https://doi.org/10.1016/..
 
?
15

Image_3_Real clinical experience after one year of treatmen..:

Javier Naranjo ; Francisco Borrego ; José Luis Rocha...
doi:10.3389/fmed.2022.987092.s003.  , 2022
Link: https://doi.org/10.3389/..
 
1-15